AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05968937 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Vaginal suppository composed of Supposibase F daily per vagina
Study NCT05129735 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Meal replacement shake
Description: Each day for the study period (12 weeks), the participants will take one meal-replacement shake per day for breakfast. The breakfast will be replaced by the shake entirely.
Study NCT04660682 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Modified static cross-body posterior shoulder stretching
Description: For the modified cross-body position patient will be positioned in the side-lying position to limit the scapular abduction, and the patient aligned his/her forearms to limit the ER of the humerus while moving into horizontal adduction (HAdd). First, we will ask the patient to pull his/her arm into HAdd to the physiological barrier of the ROM, and then the patient will perform active-assistive static stretching with the help of the other hand for 30 seconds. The stretching will perform five repetitions with 10-sec rest between stretches. Each stretching will begin from a new physiological barrier of the HAdd ROM. Patients will also receive the standard physiotherapy program consists of physical agents, posture, proprioceptive, and strengthening exercises. The treatment program will be performed 5 days a week under the physiotherapist's supervision and 2 days a week as a home program for 8 weeks.
Study NCT04660682 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Traditional static cross-body posterior shoulder stretching
Description: For the traditional static cross-body posterior shoulder stretching, in the standing position, the patient will perform cross-body stretch alone by active-assistive pulling the humerus across the body into HAdd with the opposite arm, without concern for scapular stabilization for 30 sec. The stretching will perform five repetitions with 10-sec rest between stretches. Each stretching will begin from a new physiological barrier of the HAdd ROM. Patients will also receive the standard physiotherapy program consists of physical agents, posture, proprioceptive, and strengthening exercises. The treatment program will be performed 5 days a week under the physiotherapist's supervision and 2 days a week as a home program for 8 weeks.
Study NCT04660682 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Group
Description: In sham stretching, the patient will be positioned in the traditional static cross body posterior shoulder stretching position, and then the patient will perform active-assistive HAdd ROM without enough stretching of the relevant tissue. Active assistive ROM will be stopped before reaching the individual PST measurement result (in this way, sham stretching will be performed without proper stretching of the relevant tissue). The HAdd ROM exercise will be performed 5 times. Patients will also receive the standard physiotherapy program consists of physical agents, posture, proprioceptive, and strengthening exercises. The treatment program will be performed 5 days a week under the physiotherapist's supervision and 2 days a week as a home program for 8 weeks.
Study NCT04128371 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mepolizumab
Description: Mepolizumab is a fully humanized monoclonal antibody (IgG1, kappa mAb) supplied as 100 mg of lyophilized powder in sterile, single-dose vials. Mepolizumab 100 mg vials were reconstituted according to the manufacturer, for a total dose of 700mg administered as intravenous infusion.
Study NCT06348680 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video assisted episiotomy repair training
Description: Midwifery Intervention The 'video recording' prepared by researchers specialized in the field of midwifery to increase the episiotomy repair skills of midwifery students will be used as training material. The content of the video recording is as follows: control before episiotomy repair, episiotomy repair, subcutaneous suturing, skin suturing, suturing techniques (Continuous, Simple Intermittent, Mattress). After the video recording is completed, it will be restarted and shown to the students in the experimental group continuously throughout the application period. At the end of the application period, students will be re-evaluated.
Study NCT05126680 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Supervised exercise therapy: intermittent treadmill walking exercise and moderate intensity functional training
Description: Subjects will perform a 12-week supervised exercise therapy program based on intermittent treadmill walking exercise (15-30 min.) and moderate intensity functional training (MIFT) (15 min.). In intermittent treadmill walking exercise, the speed and incline of treadmill will be adjusted that patients achieve moderate claudication pain in the time interval between 3 and 5 min. In MIFT, subjects must complete in 15 min. the highest number of repetitions / rounds possible (AMRAP) to a circuit composed of 6 global functional exercises from which they performed 10 repetitions with a rating of perceived exertion (RPE) of 5-7 on a 1 to 10 scale in each exercise.
Study NCT05126680 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Supervised exercise therapy: intermittent treadmill walking exercise
Description: Subjects will perform a 12-week supervised exercise therapy program based on intermittent treadmill walking exercise (30-45 min.). In intermittent treadmill walking exercise, the speed and incline of treadmill will be adjusted that patients achieve moderate claudication pain in the time interval between 3 and 5 min.
Study NCT05405413 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Treatment recommendations made by Molecular Tumor Board.
Description: Molecular Tumor Board recommendations may include any of the following:~(A) a tumor-targeted drug (alone or in combination)~(B) an antibody-based immunotherapy (alone or in combination)~(C) neither (A) nor (B).~(D) referral to the Familial Cancer Program~(E) referral for germline genetic testing
Study NCT05800873 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EVER001
Description: A highly selective, oral, reversable, covalent Bruton tyrosine kinase (BTK) inhibitor with high selectivity over other kinases.
Study NCT05738629 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pluripotent Stem Cell-derived Mesenchymal Stem Cell Exosome (PSC-MSC-Exo) Eye Drops
Description: Participants will receive artificial tears for 2 weeks to get the normalized baseline, followed by PSC-MSC-Exo eye drops 0.125 ml/single eye/one time, four times a day for 12 weeks. The follow-up visit will be 12 weeks since the administration of PSC-MSC-Exo eye drops.
Study NCT05426798 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TQB2618 injection azacitidine, AZA decitabine, DAC
Description: Drug1: TQB2618 injection is a novel tim-3 inhibitor.~Drug2: Azacitidine (5-azacytidine) is a cytidine nucleoside analogue that selectively inhibits DeoxyriboNucleic Acid methyltransferases at low doses, resulting in gene promoter hypomethylation.~Drug3: Decitabine is a cytidine deoxy nucleoside analogue that selectively inhibits DNA methyltransferases at low doses, resulting in gene promoter hypomethylation.
Study NCT05713838 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: 1500 mg Durvalumab, IV, day 1 Q4W (max. 15 cycles)
Study NCT05713838 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FLOT
Description: 50 mg/m² docetaxel, 85 mg/m² oxaliplatin, 200 mg/m² calcium folinate and 2600 mg/m² fluorouracil as 24 h-infusion, 2 cycles
Study NCT05713838 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mFOLFOX-6
Description: 85 mg/m² oxaliplatin, 200 mg/m² calcium folinate, 400 mg/m² fluorouracil as bolus dose and 1600 mg/m² fluorouracil as 48 h-infusion, ² cycles
Study NCT05713838 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Description: 5 weeks with 5 days a week radiotherapy (25 daily fractions with 2.0 Gy = ∑50Gy)
Study NCT05152485 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: BIIB104 Reference Formulation
Description: Administered as specified in the treatment arm
Study NCT05152485 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIIB104 Test Formulation
Description: Administered as specified in the treatment arm
Study NCT04794088 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Imatinib Mesylate intravenous solution
Description: A 25ml volume of IMP will be administered over 2-hours as an intravenous infusion. This corresponds to a dose of 200mg imatinib (100mg/h).
Study NCT04794088 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: A 25ml volume of IMP will be administered over 2-hours as an intravenous infusion. This corresponds to a dose of 25ml placebo (12.5ml/h).
Study NCT05610514 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: E-Cigarette
Description: Altering the availability of e-cigarettes
Study NCT05610514 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Financial Incentives
Description: Altering the availability of financial incentives for abstaining from combustible cigarettes
Study NCT04698291 — intervention group
Intervention type: PROCEDURE
Intervention: Blood Donation
Description: The blood donation will take place at the Gene \& Health clinical assessment centre facilities. A trained member from Gene \& Health program will be responsible for taking the blood samples.
Study NCT05424198 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cervical Medial Branch Radiofrequency Ablation
Description: The skin and superficial tissues will be anesthetized at each site with 1-2 mL of lidocaine. Prior to the ablation up to 2 mL of lidocaine may be used at each site to ensure adequate pain control during the ablation. Once in position, a radiofrequency ablation lesion will be made using a 30 second ramp-up time to a maximum temperature of 80 °C, followed by an additional 90 seconds at maximum temperature.
Study NCT05247489 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ruxolitinib 1.5% cream
Description: Ruxolitinib cream 1.5% applied twice a day (BID).
Study NCT05726734 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vonoprazan
Description: potassium-competitive acid blocker
Study NCT05726734 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amoxicillin, Metronidazole
Description: Antibiotics for H. pylori eradication
Study NCT05726734 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amoxicillin, Metronidazole
Description: Antibiotics for H. pylori eradication
Study NCT05726734 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bismuth Potassium Citrate
Description: Gastric mucosal protective drug with anti-H. pylori effect
Study NCT05726734 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esomeprazole
Description: Proton pump inhibitor
Study NCT06320158 — intervention group
Intervention type: OTHER
Intervention: clinical evaluation of sarcopenic obesity
Description: completion of scales and questionnaires, venous blood sampling, muscle ultrasound scan
Study NCT05988281 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Type I Dental implant placement.
Description: Placement of dental implant.
Study NCT05988281 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Type II Dental implant placement.
Description: Placement of dental implant.
Study NCT05988281 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Type III/IV dental implant placement.
Description: Placement of dental implant.
Study NCT06569914 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Humanized care
Description: (1) Humanized environmental care；(2) Humanized medical guidance；(3)Humanized psychological nursing；(4) Humanized and standardized management of IVGTT treatment process
Study NCT05247489 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NB-UVB phototherapy
Description: NB-UVB (311-312 nm) phototherapy is an established treatment modality for vitiligo. Starting dose will be 200 mJ/cm2 and dose may be increased by 10% at each visit
Study NCT06211140 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: tACS
Description: tACS in 4 weeks, once per weekday for 40 minutes each, 20 sessions. The treatment group will receive transcranial alternating current stimulation at a gamma frequency (77.5Hz) with a peak amplitude of 15mA.
Study NCT05970367 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Intensive rehabilitation programme
Description: Intensive rehabilitation using advanced technology, based on the patient's goals.~Including cardiovascular fitness training, goal-oriented training, physiotherapy with and without advanced technology and self-management.
Study NCT06510075 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Health intervention
Description: Health care information delivered via a link in a text message that is then opened in a secure browser.
Study NCT06510075 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Community Health Worker
Description: Health care information delivered via CHW.
Study NCT06510075 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Digital Health Intervention plus Community Health Worker
Description: Health care information delivered via DHI plus CHW
Study NCT06344741 — intervention group
Intervention type: BEHAVIORAL
Intervention: Accepted in latent phase
Description: Participants admitted to the delivery room in the latent phase will be included. Routine procedures will be performed.
Study NCT06344741 — intervention group
Intervention type: BEHAVIORAL
Intervention: Accepted in active phase
Description: Participants admitted to the delivery room in the active phase will be included. Routine procedures will be performed.
Study NCT05030818 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Polypill of acetylsalicylic acid, ramipril and atorvastatin
Description: Administration of acetylsalicylic acid, ramipril and atorvastatin in a polypill during 3 months more
Study NCT05030818 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Drugs taken separately: acetylsalicylic acid, ramipril and atorvastatin
Description: Patients will be receiving during 3 months more the same components acetylsalicylic acid, ramipril and atorvastatin than with the polypill
Study NCT05885542 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cannabidiol oral solution
Description: Double-blind cannabidiol oral solution 800 mg administered once
Study NCT05885542 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Double-blind placebo oral solution administered once
Study NCT05137990 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HIIT Exercise Intervention
Description: Exercise trainers will provide encouragement and supervision for exercise prescription adherence and youth will select an age-appropriate music playlist from Spotify to enhance enjoyment throughout each session. Each exercise session consists of a 5-minute warm-up (10% HRmax), followed by a 20-minute HIIT protocol. The 20-minute HIIT protocol consists of seven bouts of 1-min high intensity exercise (90% HRmax) followed by 2-min of active recovery (10% HRmax). Participants will be encouraged to complete each exercise session with at least 24 hours of rest between each session.
Study NCT05137990 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Stretching Intervention
Description: This group will perform a home-based program of the same stretches utilized in the exercise group. The stretching protocol consists of one set of 4 static stretching exercises held for 30 seconds and performed 3 days/week. As flexibility exercises are low-intensity, low-impact and low-volume, minimal caloric expenditure is expected to be incurred. To increase compliance and aid in the standardization of the home-based stretching, participants will be provided a booklet of the flexibility exercises. Participants will be shown how to use the booklet and instructed in the stretching exercises by an exercise trainer prior to the intervention.
Study NCT06655285 — intervention group
Intervention type: OTHER
Intervention: This was a retrospective study and no patient intervention was performed.
Description: This was a retrospective study and no patient intervention was performed.
Study NCT06211140 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: Without the tACS stimulation in this group.
Study NCT06343155 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Therapeutic Group
Description: Pelvic tilt exercise:Participant will be supine position on the floor with your knees bent. Flatten your back against the floor by tightening your abdominal muscles and bending your pelvis up slightly. Lumbar flexion(single knee to chest): Participants will be supine position with knees bent and feet flat on the floor. The right knee will be brought closer to your chest and held with the hands. Lumbar flexion(double knee to chest) : Participants will be supine position with both legs flat on the floor. One hip and knee will be bent first to the chest, then the other to the chest. The knees will be grasped with the hands. Straight Leg Raise: Participants will be supine position with hips and legs comfortably on the floor. By contracting the quadriceps muscle the straight leg will be fixed. Inhaling slowly, the straight leg will be lifted six inches off the floor. Spine twist: Participants will turn their hips and knees to one side as much as possible in a supine position.
Study NCT06343155 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Rocabado's Group
Description: Rest position of tongue: Making a 'clucking' sound positions the tongue against the hard palate in the correct resting position for appropriate nasal and diaphragmatic breathing. Once the activity is practiced, the patient is to attempt to maintain appropriate tongue / jaw resting position throughout normal activity. Shoulder retraction:Sitting up nice and tall, squeeze your shoulder blades back and together. Stabilized head posture:Place your hands behind your hand with fingers interlocked.Gently bring head forward with gentle overpressure from hands.Axial extension of the neck: Sitting up nice and bring your chin backward as if trying to make a double chin. Rotation control of temporomandibular joint: Place tongue at the roof of your mouth just behind your front teeth and place fist underneath chin. Gently open mouth into fist and hold for a few seconds. Rhythmic stabilization:Patients apply resistance to opening, closing, and lateral deviation with the jaw in a resting position.
Study NCT06343155 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rocabado's Group
Description: Rest position of tongue: Making a 'clucking' sound positions the tongue against the hard palate in the correct resting position for appropriate nasal and diaphragmatic breathing. Once the activity is practiced, the patient is to attempt to maintain appropriate tongue / jaw resting position throughout normal activity. Shoulder retraction:Sitting up nice and tall, squeeze your shoulder blades back and together. Stabilized head posture:Place your hands behind your hand with fingers interlocked.Gently bring head forward with gentle overpressure from hands.Axial extension of the neck: Sitting up nice and bring your chin backward as if trying to make a double chin. Rotation control of temporomandibular joint: Place tongue at the roof of your mouth just behind your front teeth and place fist underneath chin. Gently open mouth into fist and hold for a few seconds. Rhythmic stabilization:Patients apply resistance to opening, closing, and lateral deviation with the jaw in a resting position.
Study NCT05526508 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Rebound exercise
Description: Exercise training on the rebounder/ mini-trampoline with stability handles attached
Study NCT06042114 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Surah Inshirah
Description: Patients in the experimental group will be listened to the Surah al-Inshirah after surgery and its effect on pain and anxiety levels will be evaluated.
Study NCT05708261 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MR Intervention
Description: Grounded in Social Cognitive Theory, the intervention delivers five 2-hour sessions with 3 post-session group check-in's to develop skills in partnership communication, HIV disclosure and prevention. The intervention utilizes self-assessments on skills learned and then action plan for these developed and then finalized in the last session.
Study NCT05708261 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Be Well Attention Match
Description: Attention match control arm providing one-way SMS of general health content delivered once per week during the first 5 weeks after enrollment.
Study NCT06554652 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lymph node tracer navigated selective neck dissection
Description: Selective lateral lymph node dissection (after injection of tracer, lymph nodes in compartment III-IV are dissected; if there is dyed lymph node in compartment IIA, then IIA is dissected).
Study NCT06554652 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Modified neck dissection
Description: Lymph nodes in compartment IIA, IIB, III, IV, VB are dissected.
Study NCT06400056 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Terbinafine
Description: FDA approved
Study NCT05580146 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Zynamite® 15% 150mg
Description: leaves of the mango food plant
Study NCT05580146 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Zynamite® 15% 300mg
Description: leaves of the mango food plant
Study NCT05580146 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Zynamite® 15% 600mg
Description: leaves of the mango food plant
Study NCT05580146 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sunflower oil matched for appearance
Study NCT06162429 — intervention group
Intervention type: PROCEDURE
Intervention: Flexible Bronchoscopy
Description: Subjects with pleural effusion who underwent medical thoracoscopy using flexible bronchoscopy